Xlife Sciences AG / Key word(s): Half Year Results28-Sep-2022 / 07:01 CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Xlife Sciences (SIX: XLS) today published its results for the first half of 2022 ending 30 June 2022. Oliver R. B.
21.09.2022 - Xlife Sciences AG / Key word(s): Miscellaneous Xlife Sciences strengthens sustainability activities with ESG strategy 21.09.2022 / 07:00 CET/CEST One of the objectives of Xlife Sciences (SIX: XLS) is to significantly strengthen and further develop . Seite 1
Xlife Sciences AG / Key word: Miscellaneous
Baader Bank initiates research coverage on Xlife Sciences
15.09.2022 / 07:00 CET/CEST
Baader Bank, one of the leading European partners. | September 15, 2022
22.08.2022 - Xlife Sciences AG / Key word(s): Miscellaneous Intron Health initiates research coverage of Xlife Sciences 22.08.2022 / 07:00 CET/CEST Intron Health today published its first independent research report on Xlife Sciences (SIX: XLS). The coverage . Seite 1
After the mergers and acquisitions (M&A) market faced uncertainty at the beginning of 2020, previously suspended transactions were driven forward, resulting in 2021 M&A activity in Switzerland.